Mark Murray

2016 - Arbutus Biopharma Corp

In 2016, Mark Murray earned a total compensation of $2.1M as President and Chief Executive Officer at Arbutus Biopharma Corp, a 54% decrease compared to previous year.

Compensation breakdown

Bonus$230,000
Option Awards$1,306,187
Salary$540,000
Other$24,784
Total$2,100,971

Murray received $1.3M in option awards, accounting for 62% of the total pay in 2016.

Murray also received $230K in bonus, $540K in salary and $24.8K in other compensation.

Rankings

In 2016, Mark Murray's compensation ranked 4,662nd out of 14,075 executives tracked by ExecPay. In other words, Murray earned more than 66.9% of executives.

ClassificationRankingPercentile
All
4,662
out of 14,075
67th
Division
Manufacturing
1,655
out of 5,486
70th
Major group
Chemicals And Allied Products
515
out of 1,900
73rd
Industry group
Drugs
380
out of 1,543
75th
Industry
Pharmaceutical Preparations
300
out of 1,173
74th
Source: SEC filing on April 18, 2017.

Murray's colleagues

We found six more compensation records of executives who worked with Mark Murray at Arbutus Biopharma Corp in 2016.

2016

Mark Kowalski

Arbutus Biopharma Corp

Chief Medical Officer

2016

Patrick Higgins

Arbutus Biopharma Corp

Former Chief Business and Commercial Operations Officer

2016

Bruce Cousins

Arbutus Biopharma Corp

Chief Financial Officer

2016

Michael Sofia

Arbutus Biopharma Corp

Chief Scientific Officer

2016

Elizabeth Howard

Arbutus Biopharma Corp

General Counsel

2016

Peter Lutwyche

Arbutus Biopharma Corp

Chief Technology Officer

News

In-depth

You may also like